Herpes zoster in COVID‐19‐positive patients

Tartari, Federico; Spadotto, Alberto; Zengarini, Corrado; Zanoni, Rossana; Guglielmo, Alba; Adorno, Alexander; Valzania, Cinzia; Pileri, Alessandro

doi:10.1111/ijd.15001

Cited by 102 publications

(142 citation statements)

References 5 publications

Supporting

Mentioning

113

Contrasting

Unclassified

Order By: Relevance

“…It can be seen as a fırst sign or during COVID-19 infection. 17,18 Our findings revealed an increased frequency of herpes zoster, which might support such previous observations. The reason for this increase might because of the high morbidity of the disease as compared to other dermatological diseases.…”

Section: Discussionsupporting

confidence: 91%

“…This multicenter study was conducted between January 12 and May 12, 2020, and dermatology departments of 15 tertiary hospitals from 13 provinces were included in the study. The hospitals were from 18 to 44 (54%) followed by 45 to 64 (28.1%), ≥65 (9.2%), and 0 to 18 years (8.6%) after the pandemic. The daily average number of patients decreased by 71.6% (227.8-64.8) in centers with higher COVID incidence; 80% (192.3-36.9) in centers with lower COVID and 77% in total centers (206.4-48) after the pandemic (P < .001).…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Multicenter study evaluating the impact of COVID ‐19 outbreak on dermatology outpatients in Turkey

Kartal

Çelik

Şendur

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

COVID-19 pandemic has a significant impact on public health, whether directly or indirectly. The first case was seen in Turkey on March 11, and the World Health Organization (WHO) declared a pandemic on March 12, 2020. The study aimed to document the effect of pandemic on dermatology outpatient clinics in Turkey. Fifteen tertiary hospitals from 13 provinces were included in the study, which was conducted between January 12 and May 12, 2020. The International Codes of Diseases (ICD-10) categories and patients' characteristics were evaluated before and after the pandemic. A total of 164 878 patients, 133 131 before and 31 747 after the pandemic, were evaluated. The daily hospital applications were found reduced by 77%. The three of the most frequent diagnoses; dermatitis, acne, and psoriasis remained unchanged after the pandemic. While the frequency of herpes zoster, scabies,

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Methodsmentioning

confidence: 99%

Multicenter study evaluating the impact of COVID ‐19 outbreak on dermatology outpatients in Turkey

Kartal

Çelik

Şendur

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

“…However, three studies with COVID-19 patients with complicated HZ described five patients with low lymphocyte count and one patient with a normal lymphocyte count. [7][8][9] Although our case's normal lymphocyte…”

Section: Discussionmentioning

confidence: 57%

Herpes zoster as a potential complication of coronavirus disease 2019

Pona

Jiwani

Afriyie

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

Although coronavirus disease 2019 (COVID-19) primarily manifests pulmonary symptoms, providers are recognizing extrapulmonary symptoms including cutaneous manifestations. Cutaneous manifestations in COVID-19 patients include acroischemic, chilblain-like eruption, petechiae and purpura, vesicles, urticaria, and erythematous maculopapules. 1 Herpes zoster (HZ) is caused by the varicella-zoster virus, which reactivates and spreads from the dorsal root ganglia to its respective dermatome. Patients at risk of HZ include elders and immunocompromised hosts. Although COVID-19 is known to affect the immune system and may increase the risk of HZ, limited reports confirm an association between HZ and COVID-19. 2,3 Here, we present a 70-year-old COVID-19 patient complicated by HZ.

show abstract

“…This contrasts with the fact that immunosuppression is held as a risk factor for reactivation. However, all four patients had lymphopenia, especially decreased CD8+ and CD3+ cells, which might have contributed to the cessation of latency [22]. Lymphopenia was also observed in a 58-year-old male from Massachusetts, who developed meningitis in addition to shingles.…”

Section: Clinical Features and Epidemiologymentioning

confidence: 77%

“…The pain and fever subsided on taking analgesics and anti-inflammatory medications-acetaminophen, tramadol, and gabapentin. [18,19,21,22,24,25]. However, in others, oral steroids [19] were also prescribed.…”

Section: Treatment and Prognosismentioning

confidence: 99%